The Transcription Factor HOXA9 Induces Expression of the Chromatin Modifier SMYD3 to Drive Leukemogenesis

Scientists identified that SET and MYND domain-containing protein 3 (SMYD3) was overexpressed in acute myeloid leukemia (AML) and predicted a poor prognosis for AML patients.